ChargePoint to feature in ITN programme on vaccine production

29-Apr-2022

The show will be presented by news anchor and journalist, Louise Minchin, and will be broadcasted on the New Scientist platform

Specialist Merseyside manufacturing business ChargePoint Technology is set to appear in an ITN production exploring its role in helping to bring the first COVID-19 vaccine to market.

The company will feature in the upcoming programme “How Vaccines Are Changing The World”, airing as part of World Immunisation Week and exploring how the roll out of COVID-19 vaccines has made vaccinations a hot topic.

The show will be presented by news anchor and journalist, Louise Minchin, and will be broadcasted on the New Scientist platform (in partnership with ITN production industry news) from 25 April. It features industry interviews and news-style reports along with sponsored editorial profiles

The programme will reportedly also explore how the pandemic has enhanced the growth of pharma manufacturing, as well as companies in the supply chain that played a role in getting vaccines to market quickly.

Chris Eccles, CEO of ChargePoint Technology, said: “The pandemic meant that the world changed in ways that no one could have imagined. At ChargePoint Technology, we supported our pharmaceutical customers in challenging times, ensuring they had the equipment they needed to maintain and scale the production of vital medicines and vaccines.

“We were on hand to help bring some of the first vaccines to market and worked around the clock to deliver vital manufacturing components in record time which enabled the manufacture of the vaccines. A customised version of our single use transfer technology was designed and manufactured in just 3 days, despite the challenges of maintaining operations during the pandemic and associated supply chain issues.”

Sign up for your free email newsletter

ChargePoint’s facility has skilled teams and machinery that create precision containment valves and single-use bags used for the safe transfer of powders during pharmaceutical manufacturing.

Companies